UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer Journal article
Chen, Yingqing, Zhang, Mingyu, Wu, Anxin, Yao, Xiaojun, Wang, Qianqian. Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer[J]. Molecules, 2022, 27(21).
Authors:  Chen, Yingqing;  Zhang, Mingyu;  Wu, Anxin;  Yao, Xiaojun;  Wang, Qianqian
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:4.2/4.6 | Submit date:2023/01/31
3039-0164  Molecular Docking  Non-small Cell Lung Cancer  Prmt5  Structure-based Virtual Screening  
Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme Journal article
Zhong H.-J., Liu L.-J., Chan D.S.-H., Wang H.-M., Chan P.W.H., Ma D.-L., Leung C.-H.. Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme[J]. Biochimie, 2014, 102(1), 211-215.
Authors:  Zhong H.-J.;  Liu L.-J.;  Chan D.S.-H.;  Wang H.-M.;  Chan P.W.H.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:27 | Submit date:2018/11/06
Inhibitor  Nedd8-activating Enzyme  Repurposing  Structure-based  Virtual Screening